“Reverse degradomics”, monitoring of proteolytic trimming by multi-CE and confocal detection of fluorescent substrates and reaction products
- 20 July 2009
- journal article
- ce and-cec
- Published by Wiley in Electrophoresis
- Vol. 30 (13), 2366-2377
- https://doi.org/10.1002/elps.200800698
Abstract
A platform for profiling of multiple proteolytic activities acting on one specific substrate, based on the use of a 96‐channel capillary DNA sequencer with CE‐LIF of labeled substrate peptides and reaction products is introduced. The approach consists of synthesis of a substrate peptide of interest, fluorescent labeling of the substrate, either aminoterminally by chemical coupling, or carboxyterminally by transglutaminase reaction, proteolysis by a biological mixture of proteases in the absence or presence of protease inhibitors, multi‐channel analysis of substrate and reaction products, and data collection and processing. Intact substrate and reaction products, even when varying by only one amino acid, can be relatively semi‐quantified in a high‐throughput manner, yielding information on proteases acting in complex biological mixtures and without prepurification. Monitoring, classification and inhibition of multiple proteolytic activities are demonstrated on a model substrate, the aminoterminus of the mouse granulocyte chemotactic protein‐2. In view of extensive processing of chemokines into various natural forms with different specific biological activities, and of the fragmentary knowledge of processing proteases, examples of processing by neutrophil degranulate, tumor cell culture fluids and plasma are provided. An example of selection and comparison of inhibitory mAbs illustrates that the platform is suitable for inhibitor screening. Whereas classical degradomics technologies analyze the substrate repertoire of one specific protease, here the complementary concept, namely the study of all proteases acting, in a biological context, on one specific substrate, is developed and tuned to identify key proteases and protease inhibitors for the processing of any biological substrate of interest.Keywords
This publication has 24 references indexed in Scilit:
- Emerging roles of proteases in tumour suppressionNature Reviews Cancer, 2007
- Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseasesNature Reviews Drug Discovery, 2007
- Proteomic discovery of protease substratesCurrent Opinion in Chemical Biology, 2007
- In search of partners: linking extracellular proteases to substratesNature Reviews Molecular Cell Biology, 2007
- Targeting neutrophil collagenase/matrix metalloproteinase-8 and gelatinase B/matrix metalloproteinase-9 with a peptidomimetic inhibitor protects against endotoxin shockBiochemical Pharmacology, 2005
- Simulation of Evolution-Selected Propeptide by High-Throughput Selection of a Peptidomimetic Inhibitor on a Capillary DNA Sequencer PlatformAnalytical Chemistry, 2005
- The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokinesThe International Journal of Developmental Biology, 2004
- Protease degradomics: A new challenge for proteomicsNature Reviews Molecular Cell Biology, 2002
- A new type of synthetic peptide library for identifying ligand-binding activityNature, 1991
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976